Showing results (161-170 of 329) with videos related to
Sort By:
Pageof 33
Journal of Thrombosis and Thrombolysis|February 11, 2012
Activated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparinMichael P Thomas, Kenneth W Mahaffey, Karen Chiswell, et al.American Heart Journal|June 23, 2014
Polymorphism of the cystatin C gene in patients with acute coronary syndromes: Results from the PLATelet inhibition and patient Outcomes studyAxel Akerblom, Niclas Eriksson, Lars Wallentin, et al.American Heart Journal|November 10, 2012
Outcome and causes of renal deterioration evaluated by serial cystatin C measurements in acute coronary syndrome patients -- results from the PLATelet inhibition and patient Outcomes (PLATO) studyAxel Akerblom, Lars Wallentin, Agneta Siegbahn, et al.Journal of Thrombosis and Thrombolysis|November 19, 2010
Heparin-associated anti-Xa activity and platelet-derived prothrombotic and proinflammatory biomarkers in moderate to high-risk patients with acute coronary syndromeRichard C Becker, Kenneth W Mahaffey, Hongqiu Yang, et al.American Heart Journal|March 31, 2015
Platelet aggregation and mental stress induced myocardial ischemia: Results from the Responses of Myocardial Ischemia to Escitalopram Treatment (REMIT) studyWei Jiang, Stephen H Boyle, Thomas L Ortel, et al.Journal of Thrombosis and Thrombolysis|September 13, 2019
Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trialAxel Åkerblom, Daniel Wojdyla, Philippe Gabriel Steg, et al.Archives of Internal Medicine|July 13, 2005
Antithrombotic therapy practices in US hospitals in an era of practice guidelinesVictor F Tapson, Thomas M Hyers, Albert L Waldo, et al.European Heart Journal. Acute Cardiovascular Care|December 24, 2019
Prognostic impact of baseline inflammatory markers in patients with acute coronary syndromes treated with ticagrelor and clopidogrelMark R Thomas, Stefan K James, Richard C Becker, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 26, 2014
Association of spontaneous and procedure-related bleeds with short- and long-term mortality after acute coronary syndromes: an analysis from the PLATO trialGregory Ducrocq, Phillip J Schulte, Richard C Becker, et al.Journal of the American Heart Association|January 14, 2018
Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) TrialThor Ueland, Axel Åkerblom, Tatevik Ghukasyan, et al.Pageof 33